External Validation of Mortality Scores among High-Risk COVID-19 Patients: A Romanian Retrospective Study in the First Pandemic Year
- PMID: 36233498
- PMCID: PMC9573119
- DOI: 10.3390/jcm11195630
External Validation of Mortality Scores among High-Risk COVID-19 Patients: A Romanian Retrospective Study in the First Pandemic Year
Abstract
Background: We aimed to externally validate three prognostic scores for COVID-19: the 4C Mortality Score (4CM Score), the COVID-GRAM Critical Illness Risk Score (COVID-GRAM), and COVIDAnalytics.
Methods: We evaluated the scores in a retrospective study on adult patients hospitalized with severe/critical COVID-19 (1 March 2020-1 March 2021), in the Teaching Hospital of Infectious Diseases, Cluj-Napoca, Romania. We assessed all the deceased patients matched with two survivors by age, gender, and at least two comorbidities. The areas under the receiver-operating characteristic curves (AUROCs) were computed for in-hospital mortality.
Results: Among 780 severe/critical COVID-19 patients, 178 (22.8%) died. We included 474 patients according to the case definition (158 deceased/316 survivors). The median age was 75 years; diabetes mellitus, malignancies, chronic pulmonary diseases, and chronic kidney and moderate/severe liver diseases were associated with higher risks of death. According to the predefined 4CM Score, the mortality rates were 0% (low), 13% (intermediate), 27% (high), and 61% (very high). The AUROC for the 4CM Score was 0.72 (95% CI: 0.67-0.77) for in-hospital mortality, close to COVID-GRAM, with slightly greater discriminatory ability for COVIDAnalytics: 0.76 (95% CI: 0.71-0.80).
Conclusion: All the prognostic scores showed close values compared to their validation cohorts, were fairly accurate in predicting mortality, and can be used to prioritize care and resources.
Keywords: COVID-19; Romania; comorbidities; mortality scores; validation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals.Intensive Care Med. 2021 Dec;47(12):1426-1439. doi: 10.1007/s00134-021-06524-w. Epub 2021 Sep 28. Intensive Care Med. 2021. PMID: 34585270 Free PMC article.
-
External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort-A Retrospective Study.J Pers Med. 2022 Oct 28;12(11):1775. doi: 10.3390/jpm12111775. J Pers Med. 2022. PMID: 36579493 Free PMC article.
-
Evaluation and Comparison of the Predictive Value of 4C Mortality Score, NEWS, and CURB-65 in Poor Outcomes in COVID-19 Patients: A Retrospective Study from a Single Center in Romania.Diagnostics (Basel). 2022 Mar 13;12(3):703. doi: 10.3390/diagnostics12030703. Diagnostics (Basel). 2022. PMID: 35328256 Free PMC article.
-
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors.BMJ Open. 2021 Sep 8;11(9):e052708. doi: 10.1136/bmjopen-2021-052708. BMJ Open. 2021. PMID: 34497086 Free PMC article. Clinical Trial.
-
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores.J Am Geriatr Soc. 2021 Jan;69(1):37-43. doi: 10.1111/jgs.16956. Epub 2020 Nov 30. J Am Geriatr Soc. 2021. PMID: 33197278 Free PMC article.
Cited by
-
Effects of COVID-19 on the Liver and Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta and Non-Delta Variants: An Analysis in a Single Centre.Pharmaceuticals (Basel). 2023 Dec 19;17(1):3. doi: 10.3390/ph17010003. Pharmaceuticals (Basel). 2023. PMID: 38275989 Free PMC article.
-
COVID-19 and Laboratory Markers from Romanian Patients-A Narrative Review.Life (Basel). 2023 Aug 30;13(9):1837. doi: 10.3390/life13091837. Life (Basel). 2023. PMID: 37763241 Free PMC article. Review.
References
-
- Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–1581. doi: 10.1001/jama.2020.5394. Erratum in JAMA 2021, 325, 2120. - DOI - PMC - PubMed
-
- Karagiannidis C., Mostert C., Hentschker C., Voshaar T., Malzahn J., Schillinger G., Klauber J., Janssens U., Marx G., Weber-Carstens S., et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: An observational study. Lancet Respir. Med. 2020;8:853–862. doi: 10.1016/S2213-2600(20)30316-7. - DOI - PMC - PubMed
-
- Dongelmans D.A., Termorshuizen F., Brinkman S., Bakhshi-Raiez F., Arbous M.S., de Lange D.W., van Bussel B.C.T., de Keizer N.F., Verbiest D.P., Velde L.F.T., et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: A nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Ann. Intensive Care. 2022;12:1–10. doi: 10.1186/s13613-021-00978-3. - DOI - PMC - PubMed
-
- Guidet B., Jung C., Flaatten H., Fjølner J., Artigas A., Pinto B.B., Schefold J.C., Beil M., Sigal S., van Heerden P.V., et al. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med. 2022;48:435–447. doi: 10.1007/s00134-022-06642-z. - DOI - PMC - PubMed
-
- Wynants L., Van Calster B., Collins G.S., Riley R.D., Heinze G., Schuit E., Bonten M.M.J., Dahly D.L., Damen J.A., Debray T.P.A., et al. Prediction models for diagnosis and prognosis of COVID-19: Systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328. Updated in BMJ 2021, 372, n236, Erratum in BMJ 2020, 369, m2204. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources